Scalper1 News
After-hours action was busy, with LinkedIn (LNKD) continuing social networks’ poorly received reports, solar stocks falling short on revenue and Gilead Sciences (GILD) crushing estimates on its latest hepatitis drug. Meanwhile, Tesla Motors (TSLA) awaited its much-hyped battery announcement. LinkedIn stock shares plummeted 21% in late trading despite a first-quarter beat, as the social media site for professionals provided weak Q2 earnings and Scalper1 News
Scalper1 News